Lexaria Bioscience Corp. - *W EXP 01/14/202 (LEXXW)

CUSIP: 52886N117

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / *W EXP 01/14/202
Total 13F shares
23,119
Share change
-20,656
Total reported value
$97
Price per share
$0.00
Number of holders
2
Value change
-$3,397
Number of buys
2
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 52886N117?
CUSIP 52886N117 identifies LEXXW - Lexaria Bioscience Corp. - *W EXP 01/14/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Lexaria Bioscience Corp. - *W EXP 01/14/202 (LEXXW) as of Q4 2025

As of 31 Dec 2025, Lexaria Bioscience Corp. - *W EXP 01/14/202 (LEXXW) was held by 2 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,119 shares. The largest 2 holders included TWO SIGMA SECURITIES, LLC and Clear Street Group Inc.. This page lists 2 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.